Glycemic variability and acute ischemic stroke: the missing link?

Area of Science:

• Neurology
• Endocrinology
• Clinical Medicine

Background:

• Hyperglycemia is common in acute ischemic stroke patients, regardless of diabetes status.
• Experimental models show hyperglycemia exacerbates brain damage, inflammation, and vascular issues in stroke.
• Previous therapeutic attempts to control hyperglycemia in stroke yielded conflicting results.

Purpose of the Study:

• To review the impact of hyperglycemia on acute ischemic stroke.
• To explore the potential role of glycemic variability as a predictor of stroke outcomes.
• To identify novel therapeutic targets beyond simple glucose control.

Main Methods:

• Literature review of studies on hyperglycemia and stroke.
• Analysis of experimental data linking hyperglycemia to neurotoxicity.
• Examination of research on glycemic variability in critical care and its potential application to stroke.

Main Results:

• Hyperglycemia is consistently associated with poorer clinical outcomes in stroke.
• Intensive glycemic control strategies have shown inconsistent benefits in stroke patients.
• Glycemic variability is a known outcome predictor in critically ill patients but remains unevaluated in stroke.

Conclusions:

• The link between hyperglycemia and poor stroke outcomes is well-established, but therapeutic interventions have been largely unsuccessful.
• Novel approaches focusing on glycemic variability may offer new neuroprotective strategies for acute ischemic stroke.
• Further research is needed to evaluate the impact of glycemic variability on stroke prognosis and treatment.